• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Flagship reveals machine learning-based protein drug discovery startup Generate Biomedicines

cafead

Administrator
Staff member
  • cafead   Sep 10, 2020 at 11:42: PM
via The company said it had used its machine learning platform to generate multiple antibodies and peptides against the Covid-19 virus in less than 17 days and could potentially create hitherto "impossible" protein-based therapeutics.

article source